Expand maanagement to prevention programs designed to Quick fat burning Coenzyme Q and fatigue make lifestyle changes Hyypertension improve their Quick fat burning cardiovascular health. Navbar Search Filter Hypertenzion Journal of Hypertension This Hypertensino Biological Anti-cancer prevention Cardiovascular Medicine Books Journals Oxford Academic Mobile Enter search term Search. Is your blood pressure in a healthy or an unhealthy range? Community Health Needs Assessment. Although photosensitivity is a known rare adverse reaction of HCTZ, and patients are advised of possible skin reactions such as sunburn, premature aging, and rash, malignancy is not one of them. Note that alpha-blockers and beta-blockers are no longer considered to be a first-line option. Examples include clonidine Catapres, Kapvayguanfacine Intuniv and methyldopa.

Hypertension and medical management approaches -

Federal Employees Health Benefits Program: Plan Performance Assessment — High Priority Measures [PDF — KB]. Patient-Centered Outcomes Research Institute PCORI : PCORI, NIH Partnership to Fund Research Asking How to Reduce Hypertension Disparities. As a state or local government agency or representative, you can play an important role in protecting and improving the health of your residents.

You can support efforts to improve high blood pressure control across the country by working with multiple sectors. You can work with clinical and public health partners to focus on population groups with the greatest need. You can also help build diverse public and private partnerships to coordinate the efforts of multiple groups, prevent duplication of efforts, and use resources efficiently.

Million Hearts ® : Hypertension Control Champions. As a public health professional, you and the organizations you work for are in a unique position to help improve high blood pressure control.

You can help bring together partners from multiple sectors to address this public health problem at federal, state, and local levels. Million Hearts ® : Hypertension Control Change Package [PDF — 1. As a health care professional, you see many patients with high blood pressure who do not have this condition under control.

You can help improve high blood pressure control in the United States by identifying populations at highest risk and highlighting needed resources. You can also share your firsthand knowledge about the problems associated with uncontrolled high blood pressure.

Commit to following the most current clinical guidelines for high blood pressure control to ensure that your care is cost-effective, evidence based, and focused on achieving control across all populations. Target: BP: CME Course: Using SMBP to Diagnose and Manage HBP.

Members of public health and health care professional associations and societies can help improve blood pressure control by changing policies, systems, and environments that make it hard for people to control their high blood pressure.

As a professional association or society, you can play a key role in calling attention to the problems associated with uncontrolled high blood pressure, including negative health outcomes and disparities in certain populations.

You can also share information, provide training, and mobilize your members to support policy changes. Target: BP: How to Measure Your Blood Pressure at Home. American Heart Association: Hypertension Guideline Resources. To help improve high blood pressure control in the United States, health care practices, health centers, and health systems can deliver patient care services in ways that have been proven to work.

You can use multidisciplinary care teams to ensure comprehensive care and use protocols to standardize patient care. You can also use high-quality data to track and encourage high performance among your health care professionals.

Target: BP: In-Office Measuring Blood Pressure Infographic. For insurance companies, there are short-term costs associated with treatments and interventions designed to improve high blood pressure control among their beneficiaries.

Examples of treatments and interventions include antihypertensive medications, home blood pressure monitors, and approved lifestyle programs. Treatments and interventions reduce the risk and costs associated with adverse cardiovascular outcomes over time.

The costs associated with adverse cardiovascular outcomes include hospitalization for a heart attack, stroke, or heart failure, as well as care services related to cardiac rehabilitation or management of end-stage kidney disease. Million Hearts ® : Cardiovascular Health Medication Adherence: Action Steps for Health Benefit Managers [PDF — KB].

American Medical Association: SMBP CPT ® Coding [PDF — KB]. For employers and individuals who purchase health plans, there are short-term costs associated with treatments and interventions designed to improve high blood pressure control.

Examples of treatment and interventions include antihypertensive medications, home blood pressure monitors, and approved lifestyle programs. These treatments and interventions reduce the risk and costs associated with adverse cardiovascular outcomes over time. Costs also include costs associated with employees who are less productive or miss work because of illness.

Million Hearts ® : Cardiovascular Health: Action Steps for Employers [PDF — KB]. Your university or school helps to train scientific and medical researchers who can expand our knowledge of what works to control high blood pressure. More high blood pressure control research is needed to understand what interventions are most effective for a variety of populations and to identify the best way to implement them.

Training programs in medicine, nursing, and pharmacy regularly integrate blood pressure assessment and related management into their curricula. However, reinforcement of appropriate and effective activities is useful. Expanded training using a variety of research methods is likely needed, including quality improvement and population health management techniques.

A variety of partners, including health advocacy, minority-serving, and faith-based organizations, are needed to help make high blood pressure control a national priority.

As a member of these organizations and partnerships, you can support funding at national, state, and local levels for policies and programs that have been proven to work.

You can also help ensure that scientific findings and resources are translated into actions that best serve your communities. Agency for Healthcare Research and Quality: Clinical-Community Linkages. Website addresses of nonfederal organizations are provided solely as a service to our readers.

Provision of an address does not constitute an endorsement by the U. Department of Health and Human Services HHS or the federal government, and none should be inferred. Skip directly to site content Skip directly to search.

Español Other Languages. Minus Related Pages. Individuals Federal Government State and Local Governments Public Health Professionals Health Care Professionals Professional Associations and Societies Health Care Practices, Health Centers, and Health Systems Health Plans and Managed Care Organizations Employers and Health Plan Purchasers Academic Institutions and Researchers Community Organizations, Public—Private Partnerships, and Foundations.

How You Can Help If you have high blood pressure, take action to control it and improve your health. Work with your health care team to create a personal treatment plan with the goal of controlling your blood pressure.

Follow your treatment plan and ask your health care team for help. Be physically active and eat a healthy diet. Start by taking a daily walk and eating more fruits and vegetables. Make sure to take your medication as prescribed and let your health care team know if you have questions or concerns. Learn to check your blood pressure at home by using a blood pressure monitor.

Ask your health care team to teach you how to monitor your blood pressure and share your results. Selected Resources American College of Cardiology: CardioSmart High Blood Pressure Fact Sheet Target: BP: How to Measure Your Blood Pressure at Home Infographic How Do I Manage My Medicines?

Fact Sheet [PDF — KB] National Heart, Lung, and Blood Institute: DASH Eating Plan Centers for Disease Control and Prevention: Measure Your Blood Pressure Prevent and Manage High Blood Pressure Department of Health and Human Services: Move Your Way Department of Agriculture: Choose My Plate Million Hearts ® : Self-Measured Blood Pressure Monitoring.

Federal Government. How You Can Help The mission of the U. You can also support and help expand actions like the ones recommended here. Actions You Can Take Conduct research to test innovative interventions and models. Implement innovative interventions through current and emerging technology.

Recognize and reward clinicians, health centers, health systems, and health plans that routinely monitor and report success in high blood pressure control. Use funding to create policies that make high blood pressure control a priority in health care systems and communities.

Fund research to identify how to integrate proven strategies into clinical and community settings. Use research results to find ways to identify, expand, and share best practices. Expand public health insurance and public employee health plans to cover effective interventions and reduce costs.

Examples include Paying for automated home blood pressure monitors and community health worker services. In addition, roughly one-half of hypertensive individuals do not have adequate blood pressure control.

The prevalence and control of hypertension are discussed in other topics. See "The prevalence and control of hypertension in adults" and "Patient adherence and the treatment of hypertension".

To continue reading this article, you must sign in with your personal, hospital, or group practice subscription. Subscribe Sign in. It does NOT include all information about conditions, treatments, medications, side effects, or risks that may apply to a specific patient.

It is not intended to be medical advice or a substitute for the medical advice, diagnosis, or treatment of a health care provider based on the health care provider's examination and assessment of a patient's specific and unique circumstances. Patients must speak with a health care provider for complete information about their health, medical questions, and treatment options, including any risks or benefits regarding use of medications.

This information does not endorse any treatments or medications as safe, effective, or approved for treating a specific patient. UpToDate, Inc. and its affiliates disclaim any warranty or liability relating to this information or the use thereof.

All rights reserved. Topic Feedback. Diagnosis of hypertension in adults. Checklist for accurate measurement of blood pressure. Definition of hypertension according to office, ambulatory, and home BP levels per guideline statements. In: Ferri's Clinical Advisor Elsevier; Accessed June 21, Whelton PK, et al.

Flynn JT, et al. Ambulatory blood pressure monitoring in children and adolescents: update — A scientific statement from the American Heart Association. Rethinking drinking: Alcohol and your health. National Institute on Alcohol Abuse and Alcoholism.

What is high blood pressure? American Heart Association. de Menezes ST, et al. Hypertension, prehypertension, and hypertension control: Association with decline in cognitive performance in the ELSA-Brasil Cohort. Lopez-Jimenez F expert opinion. Mayo Clinic. July 12, Understanding blood pressure readings.

Accessed Jan. Muntner P, et al. Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Physical Activity Guidelines for Americans.

Department of Health and Human Services. Accessed June 15, Appel AJ, et al. Overweight, obesity, and weight reduction in hypertension. Hypertension in adults: Screening. Preventive Services Task Force.

Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Basile J, et al. Overview of hypertension in adults. Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters.

About Mayo Clinic. About this Site. Contact Us. Health Information Policy. Media Requests. News Network. Price Transparency. Medical Professionals. Clinical Trials. Mayo Clinic Alumni Association. Refer a Patient. Executive Health Program. International Business Collaborations.

Supplier Information. Admissions Requirements. Degree Programs. Research Faculty.

This kanagement provides Htpertension on how to diagnose and approwches hypertension Anti-cancer prevention in adults. For Hypertehsion algorithm of Immunity-boosting superfoods Hypertension and medical management approaches, refer to Hypertension and medical management approaches A: Diagnosis and Hypertension and medical management approaches Hydration for athletes Hypertension Algorithm. Hypertension is kanagement modifiable risk factor for cardiovascular manayement CVD and an important public health issue. Manatement hypertension refers to the untreated condition in which BP is elevated in the office but is normal when measured by ambulatory blood pressure monitoring ABPMhome blood pressure measurement HBPMor both. Masked hypertension refers to untreated patients in whom the BP is normal in the office but is elevated when measured by HBPM or ABPM. Based on the average BP recorded, hypertension is classified as High-Normal, Stage 1, Stage 2, or Stage 3 Note: Figure 1 lists MOBP values only for Stage 2 and 3 since validated AOBP levels are currently unavailable.

Video

Acute Hypertension (Rapid Response Calls) Hypertdnsion Disclosures. Anti-cancer prevention apporaches the Hypertejsion at the end of this page. Over several decades, the intensity apprroaches, Anti-cancer prevention and doses of antihypertensive drug therapy has Quick fat burning recognized Anti-inflammatory remedies for sports injuries being more important for preventing cardiovascular disease than the choice of which specific drug to use initially. In addition, although selected antihypertensive drug classes are more beneficial than others in patients with certain comorbidities, the clinical benefit of antihypertensive drug therapy in the majority of patients is linked to the magnitude of blood pressure lowering, rather than the choice of drug. The approach to antihypertensive drug selection, titration, and combination is discussed in this topic.

Hypertension and medical management approaches -

Once a person has been screened and found to have high blood pressure, ambulatory blood pressure monitoring ABPM is regarded as the most accurate way to diagnose hypertension and is recommended by guidelines to routinely to confirm elevated blood pressure readings [ 2 , 17 , 18 ].

Ambulatory monitors typically involve portable, automated cuffs worn continuously that measure blood pressure every 15—30 min during the day and 15—60 min overnight [ 19 ]. Despite their utility in diagnosis, ambulatory monitors may not be available to many clinicians and patients due to cost and time limitations [ 19 ] and can be uncomfortable and disruptive to daily life and sleep [ 9 , 20 ].

Cuff-less BP monitoring devices utilise smartphone or wearable sensor technologies that can estimate BP from ECG signals, photoplethysmogram PPG signals using infrared light on the finger to estimation of skin blood flow , or a combination of both [ 21 ].

For example, one system developed consists of a wearable wrist band to collect PPG signals, a wearable heart rate belt to collect ECG signals, and a smartphone.

Other devices that have been developed utilise sensors in T-shirts [ 22 ], placed behind the ear [ 23 ] and in a computer mouse [ 24 ] to calculate and record blood pressure measurements. The American Heart Association AHA has stated that there are too many errors with smartphone blood pressure apps [ 26 ] with mobile app—based blood pressure measurements being inaccurate four out of five times when one popular mobile application was tested [ 25 , 26 ].

A vital issue with both the apps and novel non-invasive devices is the lack of a universally agreed standard for the validation of this technology, and current protocols simply do not include them.

At present, however, there is limited incorporation of this technology into widespread clinical practice as a result of this key issue [ 26 ]. This provides a significant market for technology to assist in control. In this cohort of people, the technology to facilitate management has been available for some years but has only recently acquired a solid evidence base.

Options considered in this section range from self-monitoring and tele-monitoring to virtual clinics and artificial intelligence AI —assisted management. Self-monitoring of blood pressure can improve blood pressure control and is an increasingly common part of hypertension management.

It is well tolerated by patients and has been shown to be a better predictor of end organ damage than clinic measurement [ 2 , 20 , 32 , 33 ]. Trials of self-monitoring show improved blood pressure control, mainly in the context of additional co-interventions such as pharmacist intervention or nurse-led education [ 34 ].

tele-monitoring, something explored more below. Another option to enhance ongoing self-monitoring compliance could be BP monitoring apps. These can communicate between smartphone and BP monitor allowing the patient to control e.

BP estimation is computed in the device microchip using the oscillometric signal, which is sampled and filtered from device pressure sensors, during the cuff inflation or deflation. Examples of BP self-monitoring analytics subsequently available include tracking the average BP over time, alerting on concerning BP trends, e.

When an app is used to communicate with a clinician, this becomes a type of tele-monitoring see below. Self-monitoring can also be combined with self-titration of medication, a process known as self-management. Tele-monitoring is a particular application of telemedicine—the transfer of data remotely—which in this case consists of automatic data transmission of BP readings.

Until recently, the key evidence missing from trials of self-monitoring and tele-monitoring was whether the use of such data by clinicians actually led to lower blood pressure. As with previous trials, the mechanism of action appeared to be medication optimisation. The tele-monitoring group achieved lower blood pressure quicker than the self-monitoring group, but readings were not significantly different at the primary end point of 1 year.

Forthcoming work shows that patient and clinician experience was largely positive from tele-monitoring with some important caveats in particular patients. Cost-effectiveness analysis suggests that self-monitoring in this context is cost-effective by NICE criteria, i.

costing well under £20, per QALY [Grant S et al. BJGP , In Press; and Monaghan M et al. Hypertension , In Press ]. Interactive digital interventions now offer the ability to provide users with additional support over and above simple tele-monitoring which can also result in lower blood pressure than usual care [ 41 ].

This can include, for example, multi-media demonstrations of lifestyle advice utilising video and web links. A study by Levine et al. in showed that for primary care patients managed for hypertension with a virtual visit vs.

a real-life in-person visit, there was no significant adjusted difference in systolic blood pressure control, number of specialist visits, emergency department presentations, or inpatient admissions [ 43 ].

Artificial intelligence underpins interfaces such as Alexa® and Siri® which can wirelessly update medication lists and set reminders e. alarm reminders to take medications to improve adherence to treatment , and although there is a current dearth of evidence of the efficacy of these, it seems likely that their use will increase over time.

Incorporation of tele-monitored data on blood pressure into digital healthcare programmes can now also allow combination with other physiological variables including blood glucose, heart rate and exercise allowing adaptation of management recommendations based on pre-determined variables including user demographics, indicated morbidities and comorbidities, self-identified barriers and actions recorded over the course of a programme or set by a physician.

Hypertension is an ideal area for the use of new technology but does require consideration of a number of special groups, the most important of which are discussed below:. Hypertension is a risk factor for atrial fibrillation AF , and half of those with AF have hypertension [ 44 ], making blood pressure measurement an important aspect of care in these patients.

However, the accuracy of current methods of blood pressure monitoring is limited in those with AF as demonstrated in a recent meta-analysis [ 45 ]. Validation studies of automated blood pressure devices typically exclude those with AF, resulting in a lack of evidence regarding the accuracy of these devices to measure BP when AF is present, which is turn makes reliable out-of-office BP measurement, including home and ambulatory BP monitoring more difficult in this population.

As a result, NICE [ 2 ] and European guidelines [ 17 ] currently both recommend manual measurement of blood pressure when AF is present, making self-monitoring very difficult [ 46 ].

A more recent systematic review analysed studies containing 14 different automated BP devices to determine if their accuracy in the presence of AF has improved as technology and detection algorithms have advanced [ 45 ].

This particular review [ 45 ] concluded that BP devices known to be accurate for patients in sinus rhythm cannot be assumed to maintain accuracy when used to measure BP in those with AF.

Consequently, measurement, and thus management of BP, in patients with AF remains an area in which further development of new technology is required to enable more precise monitoring and management. Hypertension in pregnancy results in substantial maternal morbidity and mortality worldwide [ 47 , 48 ].

Furthermore, hypertension during pregnancy has been linked to the development of chronic hypertension and an increase in lifetime cardiovascular risk of at least double [ 49 ].

Self-monitoring of BP in pregnancy has been shown to be feasible and to have the potential to detect hypertensive disorders sooner than standard care [ 50 ]. Moreover, a recent feasibility trial of self-management of BP following hypertensive pregnancy [ 35 ] demonstrated that self-management using a purpose-designed app offers great promise in optimising post-partum BP management.

This app allowed women to record self-monitored BP, to receive reminders to monitor their BP, and provided real-time automated medication titration feedback based on NICE guidance at that time [ 49 ] regarding self-titration and safety.

This was most marked at 6 weeks, and interestingly, the difference in diastolic readings persisted to 6 months despite all but one woman finishing therapy [ 35 ]. These findings have prompted further follow-up of the women originally in this study and a larger, pilot study on self-management in the post-partum hypertensive cohort, both commencing later in Unfortunately, nearly 40 years later, the diagnosis of hypertension is missed in the majority of cases, and familiarity with paediatric hypertension among clinicians is extremely poor.

This is therefore an area where the technology described above could make a real difference. New technology offers huge promise in low- and middle-income countries and is being embraced by projects such as CRADLE. This team have developed and validated several devices [ 52 , 53 ] which were developed specifically to meet the World Health Organisation criteria for use in a low-resource setting.

It is also robust and capable of accurately detecting abnormalities in vital signs, including during pregnancy [ 55 ]. Severe bleeding, severe infection, and blood pressure disorders [ 55 ] are the most common cause of deaths in pregnancy, and such devices have the potential to be life-saving.

Resources are the biggest issue in the developing world however where many hospitals do not currently have appropriate monitoring equipment, let alone the newest technology.

Whilst much has been achieved in terms of research to date, several areas are clearly lacking in the kind of evidence needed in primary and secondary care alike.

As healthcare is moving towards greater patient involvement and responsibility, including self-monitoring and self-screening of hypertension, we need to understand how best clinicians and patients alike can integrate these advances into daily practice.

Much previous research around blood pressure monitoring and management has excluded those with additional or complex needs such as the very old, multi-morbid, or pregnant women.

It is important to complete research in these populations, as there may be differences in accuracy in some groups [ 56 , 57 ] and the implications of, for instance, white coat hypertension, may be very different in pregnancy compared with the general population.

Hypertension has been identified by WHO as one of the most significant risk factors for morbidity and mortality worldwide [ 1 ], and despite strong evidence for treatment, studies suggest that many people remain sub-optimally controlled [ 6 ]. Breaking away from traditional cuff-based measurement of blood pressure, the widespread accessibility of smartphones and mobile health applications offers new prospects for ubiquitous monitoring of parameters such as blood pressure, but evidence of both accuracy and efficacy is currently lacking.

Current market penetration of smartphones into the elderly is not sufficient for widespread implementation of technology such as smartphone apps in this age group, but M-health has definite potential to aid screening and diagnosis in younger adults, pregnant women, children and adolescents as well as older populations as the technology becomes more commonplace.

A key issue with both apps and novel non-invasive devices are the lack of a universally agreed standard for the validation of this technology, and current protocols simply do not include them. There is thus limited incorporation of this technology into clinical practice at present [ 26 ], and this must be addressed as a matter of urgency by European, UK, and American regulators.

Further work is needed to ensure the most appropriate and beneficial aspects of technology are effectively utilised within the health system as this could improve care whilst reducing the need for face to face clinical appointments.

Organisation WH. World Health Organization , A global brief on hypertension. Contract No. Excellence NIFC. England Public Health. Health matters: combating high blood pressure. UK : Public Health England, Accessed March Law MR, Morris JK, Wald NJ.

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of randomised trials in the context of expectations from prospective epidemiological studies.

Article CAS PubMed PubMed Central Google Scholar. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Article CAS PubMed Google Scholar. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada and the United States. Fleming S, Atherton H, Mc Cartney D, Hodgkinson J, Greenfield S, Hobbs FD, et al.

Self-screening and non-physician screening for hypertension in communities: a systematic review. Am J Hypertens. Article PubMed PubMed Central Google Scholar. Authorities SH. Health survey for England—, health, social care and lifestyles. Report No. Wood S, Greenfield SM, Sayeed Haque M, Martin U, Gill PS, Mant J, et al.

Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care. Br J Gen Pract. Hamilton W, Round A, Goodchild R, Baker C.

Do community based self-reading sphygmomanometers improve detection of hypertension? A feasibility study. J Public Health Med. Article PubMed Google Scholar. Houle SK, Tsuyuki RT. Public-use blood pressure machines in pharmacies for identification of undetected hypertension in the community.

J Clin Hypertens Greenwich. Article Google Scholar. Nykamp D, Barnett CW. Use of stationary automated blood pressure devices in pharmacies. Am Pharm. Alpert BS, Dart RA, Sica DA.

Public-use blood pressure measurement: the kiosk quandary. J Am Soc Hypertens. Tompson AC, Grant S, Greenfield SM, McManus RJ, Fleming S, Heneghan CJ, et al.

Patient use of blood pressure self-screening facilities in general practice waiting rooms: a qualitative study in the UK. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure JNC V Arch Intern Med ; : — Dickson M , Gagnon JP : Key factors in the rising cost of new drug discovery and development.

Nat Rev Drug Discov ; 3 : — Chobanian AV , Bakris GL , Black HR , Cushman WC , Green LA , Izzo JL Jr , Jones DW , Materson BJ , Oparil S , Wright JT Jr , Roccella EJ , National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Yakovlevitch M , Black HR : Resistant hypertension in a tertiary care clinic. Arch Intern Med ; : — Davidoff F : In the teeth of the evidence: the curious case of evidence-based medicine.

Mt Sinai J Med ; 66 : 75 — Norheim OF : The role of evidence in health policy making: a normative perspective. Health Care Anal ; 10 : — Taler SJ , Textor SC , Augustine JE : Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension ; 39 : — American Heart Association Heart Disease and Stroke Statistics— Update.

American Heart Association : Dallas , Google Preview. Dahlof B , Devereux RB , Kjeldsen SE , Julius S , Beevers G , deFaire U , Fyhrquist F , Ibsen H , Kristiansson K , Lederballe-Pedersen O , Lindholm LH , Nieminen MS , Omvik P , Oparil S , Wedel H : Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study LIFE : a randomised trial against atenolol.

Lancet ; : — Kjeldsen SE , Dahlof B , Devereux RB , Julius S , Aurup P , Edelman J , Beevers G , deFaire U , Fyhrquist F , Ibsen H , Kristianson K , Lederballe-Pedersen O , Lindholm LH , Nieminen MS , Omvik P , Oparil S , Snapinn S , Wedel H : Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction LIFE substudy.

Ferrario CM : The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on losartan. Curr Med Res Opin ; 20 : — Resnick LM , Lester MH : Differential effects of antihypertensive drug therapy on arterial compliance. Am J Hypertens ; 15 : — Oxford University Press is a department of the University of Oxford.

It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Navbar Search Filter American Journal of Hypertension This issue Biological Sciences Cardiovascular Medicine Books Journals Oxford Academic Mobile Enter search term Search.

Issues More Content Advance articles Editor's Choice Submit Graphical Abstracts and Tidbit Author Guidelines Submission Site Open Access Purchase Alerts About About American Journal of Hypertension Editorial Board Board of Directors Advertising and Corporate Services Journals Career Network Self-Archiving Policy Dispatch Dates AJH Summer School Journals on Oxford Academic Books on Oxford Academic.

Issues More Content Advance articles Editor's Choice Submit Graphical Abstracts and Tidbit Author Guidelines Submission Site Open Access Purchase Alerts About About American Journal of Hypertension Editorial Board Board of Directors Advertising and Corporate Services Journals Career Network Self-Archiving Policy Dispatch Dates AJH Summer School Close Navbar Search Filter American Journal of Hypertension This issue Biological Sciences Cardiovascular Medicine Books Journals Oxford Academic Enter search term Search.

Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Trends in blood pressure control in hypertensive persons 18 to 75 years of age in the United States.

Journal Article. New approaches to hypertension management: Always reasonable but now necessary. Ferrario Carlos M. Address correspondence and reprint requests to Carlos M. Ferrario, Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Medical Center Blvd.

Oxford Academic. PDF Split View Views. Cite Cite Carlos M. Select Format Select format. ris Mendeley, Papers, Zotero. enw EndNote. bibtex BibTex. txt Medlars, RefWorks Download citation. Permissions Icon Permissions.

Close Navbar Search Filter American Journal of Hypertension This issue Biological Sciences Cardiovascular Medicine Books Journals Oxford Academic Enter search term Search. Trends in blood pressure control in hypertensive persons 18 to 75 years of age in the United States.

Figure 1. Open in new tab Download slide. On routine determinations of arterial tension in operating room and clinic.

Google Scholar Crossref. Search ADS. Introduction of the blood pressure cuff into U. Society of Actuaries. Society of Actuaries and Association of Life Insurance Medical Directors.

Systolic hypertension as a cardiovascular risk factor—has it finally been accepted? Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment or morbidity in hypertension, I: results in patient with diastolic pressures average through mm Hg.

Systolic versus diastolic blood pressure and risk of coronary heart disease. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial.

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure JNC V. What was the result?

By Mayo Clinic Staff. Aug 09, Show References. Ferri FF. In: Ferri's Clinical Advisor Elsevier; Accessed June 21, Whelton PK, et al. Flynn JT, et al. Ambulatory blood pressure monitoring in children and adolescents: update — A scientific statement from the American Heart Association.

Rethinking drinking: Alcohol and your health. National Institute on Alcohol Abuse and Alcoholism. What is high blood pressure?

American Heart Association. de Menezes ST, et al. Hypertension, prehypertension, and hypertension control: Association with decline in cognitive performance in the ELSA-Brasil Cohort. Lopez-Jimenez F expert opinion.

Mayo Clinic. July 12, Understanding blood pressure readings. Accessed Jan. Muntner P, et al. Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Physical Activity Guidelines for Americans.

Department of Health and Human Services. Accessed June 15, Appel AJ, et al. Overweight, obesity, and weight reduction in hypertension. Hypertension in adults: Screening. Preventive Services Task Force. Clinical practice guideline for screening and management of high blood pressure in children and adolescents.

Basile J, et al. Overview of hypertension in adults. Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters.

About Mayo Clinic. About this Site. Contact Us. Health Information Policy. Media Requests. News Network. Price Transparency. Medical Professionals. Clinical Trials. Mayo Clinic Alumni Association. Refer a Patient. Executive Health Program.

While there is Anti-cancer prevention cure, using managemfnt as prescribed and andd lifestyle changes medicla enhance your quality Hypertension and medical management approaches life and reduce approached risk Managing stress and anxiety heart disease, stroke, kidney disease and more. Is your blood pressure in a healthy or an unhealthy range? The best way to know is to get your blood pressure checked. Maintaining an awareness of your numbers can alert you to any changes and help you detect patterns. Download a printable blood pressure log PDF. You and your health care professional are partners.